AstraZeneca sold its stake in Moderna for more than $ 1 billion: The Times By Reuters

AstraZeneca sold its stake in Moderna for more than $ 1 billion: The Times By Reuters

by

© Reuters. AstraZeneca office building in Brussels

(Reuters) – AstraZeneca (NASDAQ 🙂 Plc sold its 7.7% stake in Modern (NASDAQ 🙂 Inc for more than $ 1 billion after the US biotech firm’s stock soared due to the discovery of the coronavirus vaccine, The Times reported.

The report added that it was unclear when Britain-based AstraZeneca sold its stake in Moderna.

AstraZeneca and Moderna did not immediately respond to requests for comment.

AstraZeneca is partnering with Moderna on other disease treatments and may sell its COVID-19 AstraZeneca / Oxford University vaccine on a commercial basis in the future if the virus becomes endemic, the report added.

Moderna, whose vaccine is released for emergency use against COVID-19 in the United States, said last week that it expected sales of $ 18.4 billion of its coronavirus vaccine this year.

Disclaimer: Fusion Media I would like to remind you that the data contained on this website are not necessarily real-time or accurate. All CFDs (stocks, indices, futures) and Forex prices are not provided by exchanges, but by market makers, and therefore prices may not be accurate and may differ from the actual market price, which means that Prices are indicative and not appropriate for commercial purposes. Therefore, Fusion Media assumes no responsibility for any commercial losses that you may incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of relying on information, including data, quotes, charts and buy / sell signals contained on this website. Be fully informed about the risks and costs associated with trading on the financial markets, it is one of the most risky forms of investment possible.

Source